Angel S. Willis
Known title: EVP, GC & Corp Affrs OfcrCIK: 0001812998
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Kraft Heinz Faces Worsening U.S. Sales Amid $700M Turnaround. Kraft Heinz faces worsening U.S. sales as it ramps up $700 million in spending for a business overhaul. The company is also entering the Canadian ready-to-eat soup market. With the stock trading near its 52-week low, investors are watching how these operational changes affect the firm's high dividend yield.
Transaction History
| SPXC | ▲ Buy | Grant | 754 | — | 5/12/2026 | View on chart |
| KHC | ▲ Buy | Grant | 4,127 | $102K | 3/1/2026 | View on chart |
| KHC | ▲ Buy | Grant | 32,914 | $0 | 3/1/2026 | View on chart |
| KHC | ▲ Buy | Grant | 13,755 | $0 | 3/1/2026 | View on chart |
| KHC | ▲ Buy | Grant | 34,534 | $0 | 9/3/2025 | View on chart |
| SPXC | ▲ Buy | Grant | 892 | — | 5/13/2025 | View on chart |
| KHC | ▲ Buy | Grant | 15,826 | $0 | 3/1/2025 | View on chart |
| KHC | ▲ Buy | Grant | 1,678 | $0 | 3/1/2025 | View on chart |
| KHC | ▲ Buy | Grant | 504 | $15K | 3/1/2025 | View on chart |
| SPXC | ▲ Buy | Grant | 998 | — | 5/14/2024 | View on chart |
| SPXC | ▲ Buy | Grant | 1,770 | — | 5/9/2023 | View on chart |
| SPXC | ▲ Buy | Grant | 2,882 | — | 5/10/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
SPXC receives analyst coverage and growth focus
Recent analyst notes emphasize SPX Technologies' growth profile, citing its market position and revenue trends. Oppenheimer kept an Outperform rating but adjusted its price target to $270, reflecting a more modest outlook. A separate piece highlighted the compound return of a $100 investment over 15 years, underscoring the stock’s long‑term performance while it trades near the lower end of its 52‑week range.
SPXC receives analyst coverage and growth focus. Recent analyst notes emphasize SPX Technologies' growth profile, citing its market position and revenue trends. Oppenheimer kept an Outperform rating but adjusted its price target to $270, reflecting a more modest outlook. A separate piece highlighted the compound return of a $100 investment over 15 years, underscoring the stock’s long‑term performance while it trades near the lower end of its 52‑week range.